Nanoparticles as antituberculosis drugs carriers: effect on activity against Mycobacterium tuberculosis in human monocyte-derived macrophages

被引：60

作者：

Anisimova, Y. V. ^{[1
]}

Gelperina, S. I. ^{[1
]}

Peloquin, C. A. ^{[1
]}

Heifets, L. B. ^{[1
]}

机构：

[1] Natl Jewish Med & Res Ctr, Denver, CO 80206 USA

来源：

JOURNAL OF NANOPARTICLE RESEARCH | 2000年 / 2卷 / 02期

关键词：

tuberculosis; nanoparticles; antituberculosis drugs; Mycobacterium tuberculosis; drug delivery;

D O I：

10.1023/A:1010061013365

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

This is the first report evaluating the nanoparticle delivery system for three antituberculosis drugs: isoniazid, rifampin, and streptomycin. The typical particle size is 250 nm. We studied accumulation of these drugs in human monocytes as well as their antimicrobial activity against Mycobacterium tuberculosis residing in human monocyte-derived macrophages. Nanoparticle encapsulation increased the intracellular accumulation (cell-association) of all three tested drugs, but it enhanced the antimicrobial activity of isoniazid and streptomycin only. On the other hand, the activity of encapsulated rifampin against intracellular bacteria was not higher than that of the free drug.

引用

页码：165 / 171

页数：7

共 50 条

[1] Nanoparticles as Antituberculosis Drugs Carriers: Effect on Activity Against Mycobacterium tuberculosis in Human Monocyte-Derived Macrophages
Y.V. Anisimova
S.I. Gelperina
C.A. Peloquin
L.B. Heifets
Journal of Nanoparticle Research, 2000, 2 : 165 - 171
[2] Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages
Heifets, L
Higgins, M
Simon, B
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (06) : 491 - 495
[3] Mycobacterium tuberculosis 38-kDa Lipoprotein is Apoptogenic for Human Monocyte-derived Macrophages
Sanchez, A.
Espinosa, P.
Esparza, M. A.
Colon, M.
Bernal, G.
Mancilla, R.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2009, 69 (01) : 20 - 28
[4] The functional response of human monocyte-derived macrophages to serum amyloid A and Mycobacterium tuberculosis infection
Kawka, Malwina
Plocinska, Renata
Plocinski, Przemyslaw
Pawelczyk, Jakub
Slomka, Marcin
Gatkowska, Justyna
Dzitko, Katarzyna
Dziadek, Bozena
Dziadek, Jaroslaw
FRONTIERS IN IMMUNOLOGY, 2023, 14
[5] Mycobacterium tuberculosis infection of human monocyte-derived macrophages leads to apoptosis of T cells
Sharma, Sadhna
Sharma, Monika
Bose, Mridula
IMMUNOLOGY AND CELL BIOLOGY, 2009, 87 (03): : 226 - 234
[6] Type I IFN Responses to Mycobacterium Tuberculosis Infection in Human Alveolar Macrophages Compared to Monocyte-Derived Macrophages
Patino, M. Campo
Dill-McFarland, K. A.
Peterson, G. J.
Skerrett, S. J.
Hawn, T. R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[7] Human Alveolar and Monocyte-Derived Human Macrophage Responses to Mycobacterium tuberculosis
Campo, Monica
Dill-McFarland, Kimberly A.
Peterson, Glenna J.
Benson, Basilin
Skerrett, Shawn J.
Hawn, Thomas R.
JOURNAL OF IMMUNOLOGY, 2024, 213 (02): : 161 - 169
[8] Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis
Goletti, D
Carrara, S
Vincenti, D
Giacomini, E
Fattorini, L
Garbuglia, AR
Capobianchi, MR
Alonzi, T
Fimia, GM
Federico, M
Poli, G
Coccia, E
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (04): : 624 - 633
[9] Diminished adherence and/or ingestion of virulent Mycobacterium tuberculosis by monocyte-derived macrophages from patients with tuberculosis
Zabaleta, J
Arias, M
Maya, JR
Garcia, LF
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (05) : 690 - 694
[10] CpG oligonucleotides partially inhibit growth of Mycobacterium tuberculosis, but not Salmonella or Listeria, in human monocyte-derived macrophages
Wang, JP
Hayashi, T
Datta, SK
Kornbluth, RS
Raz, E
Guiney, DG
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2005, 45 (02): : 303 - 310

← 1 2 3 4 5 →